Global Antisense and RNAi Therapeutics Market Professional Survey Report 2017

November 2017 | 116 pages | ID: G41C204225FEN
QYResearch

Abstracts

This report studies Antisense and RNAi Therapeutics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Glaxo Smith Kline
• Sanofi Aventis / Genzyme
• Isis Pharmaceuticals/ Ionis Pharmaceuticals
• Arbutus Biopharma Ltd.
• Silence Therapeutics
• Bio-Path Holdings Inc.
• Calando Pharmaceuticals
• ICo Therapeutics
• Quark Pharmaceuticals
• Rexhan Pharmaceuticals
• Biomarin/Prosensa
• Regulus Therapeutics
• Rxi Pharmaceuticals
• Silenseed
• Dicerna Pharmaceuticals
• Sirnaomics Inc

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• RNA interference
• SiRNA
• MiRNA
• Antisense RNA

By Application, the market can be split into

• Oncology
• Cardiovascular
• Renal
• Neurodegenerative
• Respiratory
• Genetic
• Infectious Diseases

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Antisense and RNAi Therapeutics Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF ANTISENSE AND RNAI THERAPEUTICS

1.1 Definition and Specifications of Antisense and RNAi Therapeutics
  1.1.1 Definition of Antisense and RNAi Therapeutics
  1.1.2 Specifications of Antisense and RNAi Therapeutics
1.2 Classification of Antisense and RNAi Therapeutics
  1.2.1 RNA interference
  1.2.2 SiRNA
  1.2.3 MiRNA
  1.2.4 Antisense RNA
1.3 Applications of Antisense and RNAi Therapeutics
  1.3.1 Oncology
  1.3.2 Cardiovascular
  1.3.3 Renal
  1.3.4 Neurodegenerative
  1.3.5 Respiratory
  1.3.6 Genetic
  1.3.7 Infectious Diseases
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF ANTISENSE AND RNAI THERAPEUTICS

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Antisense and RNAi Therapeutics
2.3 Manufacturing Process Analysis of Antisense and RNAi Therapeutics
2.4 Industry Chain Structure of Antisense and RNAi Therapeutics

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF ANTISENSE AND RNAI THERAPEUTICS

3.1 Capacity and Commercial Production Date of Global Antisense and RNAi Therapeutics Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Antisense and RNAi Therapeutics Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Antisense and RNAi Therapeutics Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Antisense and RNAi Therapeutics Major Manufacturers in 2016

4 GLOBAL ANTISENSE AND RNAI THERAPEUTICS OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Antisense and RNAi Therapeutics Capacity and Growth Rate Analysis
  4.2.2 2016 Antisense and RNAi Therapeutics Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Antisense and RNAi Therapeutics Sales and Growth Rate Analysis
  4.3.2 2016 Antisense and RNAi Therapeutics Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Antisense and RNAi Therapeutics Sales Price
  4.4.2 2016 Antisense and RNAi Therapeutics Sales Price Analysis (Company Segment)

5 ANTISENSE AND RNAI THERAPEUTICS REGIONAL MARKET ANALYSIS

5.1 North America Antisense and RNAi Therapeutics Market Analysis
  5.1.1 North America Antisense and RNAi Therapeutics Market Overview
  5.1.2 North America 2012-2017E Antisense and RNAi Therapeutics Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Antisense and RNAi Therapeutics Sales Price Analysis
  5.1.4 North America 2016 Antisense and RNAi Therapeutics Market Share Analysis
5.2 China Antisense and RNAi Therapeutics Market Analysis
  5.2.1 China Antisense and RNAi Therapeutics Market Overview
  5.2.2 China 2012-2017E Antisense and RNAi Therapeutics Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Antisense and RNAi Therapeutics Sales Price Analysis
  5.2.4 China 2016 Antisense and RNAi Therapeutics Market Share Analysis
5.3 Europe Antisense and RNAi Therapeutics Market Analysis
  5.3.1 Europe Antisense and RNAi Therapeutics Market Overview
  5.3.2 Europe 2012-2017E Antisense and RNAi Therapeutics Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Antisense and RNAi Therapeutics Sales Price Analysis
  5.3.4 Europe 2016 Antisense and RNAi Therapeutics Market Share Analysis
5.4 Southeast Asia Antisense and RNAi Therapeutics Market Analysis
  5.4.1 Southeast Asia Antisense and RNAi Therapeutics Market Overview
  5.4.2 Southeast Asia 2012-2017E Antisense and RNAi Therapeutics Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Antisense and RNAi Therapeutics Sales Price Analysis
  5.4.4 Southeast Asia 2016 Antisense and RNAi Therapeutics Market Share Analysis
5.5 Japan Antisense and RNAi Therapeutics Market Analysis
  5.5.1 Japan Antisense and RNAi Therapeutics Market Overview
  5.5.2 Japan 2012-2017E Antisense and RNAi Therapeutics Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Antisense and RNAi Therapeutics Sales Price Analysis
  5.5.4 Japan 2016 Antisense and RNAi Therapeutics Market Share Analysis
5.6 India Antisense and RNAi Therapeutics Market Analysis
  5.6.1 India Antisense and RNAi Therapeutics Market Overview
  5.6.2 India 2012-2017E Antisense and RNAi Therapeutics Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Antisense and RNAi Therapeutics Sales Price Analysis
  5.6.4 India 2016 Antisense and RNAi Therapeutics Market Share Analysis

6 GLOBAL 2012-2017E ANTISENSE AND RNAI THERAPEUTICS SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Antisense and RNAi Therapeutics Sales by Type
6.2 Different Types of Antisense and RNAi Therapeutics Product Interview Price Analysis
6.3 Different Types of Antisense and RNAi Therapeutics Product Driving Factors Analysis
  6.3.1 RNA interference of Antisense and RNAi Therapeutics Growth Driving Factor Analysis
  6.3.2 SiRNA of Antisense and RNAi Therapeutics Growth Driving Factor Analysis
  6.3.3 MiRNA of Antisense and RNAi Therapeutics Growth Driving Factor Analysis
  6.3.4 Antisense RNA of Antisense and RNAi Therapeutics Growth Driving Factor Analysis

7 GLOBAL 2012-2017E ANTISENSE AND RNAI THERAPEUTICS SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Antisense and RNAi Therapeutics Consumption by Application
7.2 Different Application of Antisense and RNAi Therapeutics Product Interview Price Analysis
7.3 Different Application of Antisense and RNAi Therapeutics Product Driving Factors Analysis
  7.3.1 Oncology of Antisense and RNAi Therapeutics Growth Driving Factor Analysis
  7.3.2 Cardiovascular of Antisense and RNAi Therapeutics Growth Driving Factor Analysis
  7.3.3 Renal of Antisense and RNAi Therapeutics Growth Driving Factor Analysis
  7.3.4 Neurodegenerative of Antisense and RNAi Therapeutics Growth Driving Factor Analysis
  7.3.5 Respiratory of Antisense and RNAi Therapeutics Growth Driving Factor Analysis
  7.3.6 Genetic of Antisense and RNAi Therapeutics Growth Driving Factor Analysis
  7.3.7 Infectious Diseases of Antisense and RNAi Therapeutics Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF ANTISENSE AND RNAI THERAPEUTICS

8.1 Glaxo Smith Kline
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Glaxo Smith Kline 2016 Antisense and RNAi Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Glaxo Smith Kline 2016 Antisense and RNAi Therapeutics Business Region Distribution Analysis
8.2 Sanofi Aventis / Genzyme
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Sanofi Aventis / Genzyme 2016 Antisense and RNAi Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Sanofi Aventis / Genzyme 2016 Antisense and RNAi Therapeutics Business Region Distribution Analysis
8.3 Isis Pharmaceuticals/ Ionis Pharmaceuticals
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Isis Pharmaceuticals/ Ionis Pharmaceuticals 2016 Antisense and RNAi Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Isis Pharmaceuticals/ Ionis Pharmaceuticals 2016 Antisense and RNAi Therapeutics Business Region Distribution Analysis
8.4 Arbutus Biopharma Ltd.
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Arbutus Biopharma Ltd. 2016 Antisense and RNAi Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Arbutus Biopharma Ltd. 2016 Antisense and RNAi Therapeutics Business Region Distribution Analysis
8.5 Silence Therapeutics
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Silence Therapeutics 2016 Antisense and RNAi Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Silence Therapeutics 2016 Antisense and RNAi Therapeutics Business Region Distribution Analysis
8.6 Bio-Path Holdings Inc.
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Bio-Path Holdings Inc. 2016 Antisense and RNAi Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Bio-Path Holdings Inc. 2016 Antisense and RNAi Therapeutics Business Region Distribution Analysis
8.7 Calando Pharmaceuticals
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Calando Pharmaceuticals 2016 Antisense and RNAi Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Calando Pharmaceuticals 2016 Antisense and RNAi Therapeutics Business Region Distribution Analysis
8.8 ICo Therapeutics
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 ICo Therapeutics 2016 Antisense and RNAi Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 ICo Therapeutics 2016 Antisense and RNAi Therapeutics Business Region Distribution Analysis
8.9 Quark Pharmaceuticals
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 Quark Pharmaceuticals 2016 Antisense and RNAi Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Quark Pharmaceuticals 2016 Antisense and RNAi Therapeutics Business Region Distribution Analysis
8.10 Rexhan Pharmaceuticals
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 Rexhan Pharmaceuticals 2016 Antisense and RNAi Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 Rexhan Pharmaceuticals 2016 Antisense and RNAi Therapeutics Business Region Distribution Analysis
8.11 Biomarin/Prosensa
8.12 Regulus Therapeutics
8.13 Rxi Pharmaceuticals
8.14 Silenseed
8.15 Dicerna Pharmaceuticals
8.16 Sirnaomics Inc

9 DEVELOPMENT TREND OF ANALYSIS OF ANTISENSE AND RNAI THERAPEUTICS MARKET

9.1 Global Antisense and RNAi Therapeutics Market Trend Analysis
  9.1.1 Global 2017-2022 Antisense and RNAi Therapeutics Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Antisense and RNAi Therapeutics Sales Price Forecast
9.2 Antisense and RNAi Therapeutics Regional Market Trend
  9.2.1 North America 2017-2022 Antisense and RNAi Therapeutics Consumption Forecast
  9.2.2 China 2017-2022 Antisense and RNAi Therapeutics Consumption Forecast
  9.2.3 Europe 2017-2022 Antisense and RNAi Therapeutics Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Antisense and RNAi Therapeutics Consumption Forecast
  9.2.5 Japan 2017-2022 Antisense and RNAi Therapeutics Consumption Forecast
  9.2.6 India 2017-2022 Antisense and RNAi Therapeutics Consumption Forecast
9.3 Antisense and RNAi Therapeutics Market Trend (Product Type)
9.4 Antisense and RNAi Therapeutics Market Trend (Application)

10 ANTISENSE AND RNAI THERAPEUTICS MARKETING TYPE ANALYSIS

10.1 Antisense and RNAi Therapeutics Regional Marketing Type Analysis
10.2 Antisense and RNAi Therapeutics International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Antisense and RNAi Therapeutics by Region
10.4 Antisense and RNAi Therapeutics Supply Chain Analysis

11 CONSUMERS ANALYSIS OF ANTISENSE AND RNAI THERAPEUTICS

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL ANTISENSE AND RNAI THERAPEUTICS MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Antisense and RNAi Therapeutics
Table Product Specifications of Antisense and RNAi Therapeutics
Table Classification of Antisense and RNAi Therapeutics
Figure Global Production Market Share of Antisense and RNAi Therapeutics by Type in 2016
Figure RNA interference Picture
Table Major Manufacturers of RNA interference
Figure SiRNA Picture
Table Major Manufacturers of SiRNA
Figure MiRNA Picture
Table Major Manufacturers of MiRNA
Figure Antisense RNA Picture
Table Major Manufacturers of Antisense RNA
Table Applications of Antisense and RNAi Therapeutics
Figure Global Consumption Volume Market Share of Antisense and RNAi Therapeutics by Application in 2016
Figure Oncology Examples
Table Major Consumers in Oncology
Figure Cardiovascular Examples
Table Major Consumers in Cardiovascular
Figure Renal Examples
Table Major Consumers in Renal
Figure Neurodegenerative Examples
Table Major Consumers in Neurodegenerative
Figure Respiratory Examples
Table Major Consumers in Respiratory
Figure Genetic Examples
Table Major Consumers in Genetic
Figure Infectious Diseases Examples
Table Major Consumers in Infectious Diseases
Figure Market Share of Antisense and RNAi Therapeutics by Regions
Figure North America Antisense and RNAi Therapeutics Market Size (Million USD) (2012-2022)
Figure China Antisense and RNAi Therapeutics Market Size (Million USD) (2012-2022)
Figure Europe Antisense and RNAi Therapeutics Market Size (Million USD) (2012-2022)
Figure Southeast Asia Antisense and RNAi Therapeutics Market Size (Million USD) (2012-2022)
Figure Japan Antisense and RNAi Therapeutics Market Size (Million USD) (2012-2022)
Figure India Antisense and RNAi Therapeutics Market Size (Million USD) (2012-2022)
Table Antisense and RNAi Therapeutics Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Antisense and RNAi Therapeutics in 2016
Figure Manufacturing Process Analysis of Antisense and RNAi Therapeutics
Figure Industry Chain Structure of Antisense and RNAi Therapeutics
Table Capacity and Commercial Production Date of Global Antisense and RNAi Therapeutics Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Antisense and RNAi Therapeutics Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Antisense and RNAi Therapeutics Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Antisense and RNAi Therapeutics Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Antisense and RNAi Therapeutics 2012-2017
Figure Global 2012-2017E Antisense and RNAi Therapeutics Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Antisense and RNAi Therapeutics Market Size (Value) and Growth Rate
Table 2012-2017E Global Antisense and RNAi Therapeutics Capacity and Growth Rate
Table 2016 Global Antisense and RNAi Therapeutics Capacity (K Units) List (Company Segment)
Table 2012-2017E Global Antisense and RNAi Therapeutics Sales (K Units) and Growth Rate
Table 2016 Global Antisense and RNAi Therapeutics Sales (K Units) List (Company Segment)
Table 2012-2017E Global Antisense and RNAi Therapeutics Sales Price (USD/Unit)
Table 2016 Global Antisense and RNAi Therapeutics Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Antisense and RNAi Therapeutics 2012-2017E
Figure North America 2012-2017E Antisense and RNAi Therapeutics Sales Price (USD/Unit)
Figure North America 2016 Antisense and RNAi Therapeutics Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Antisense and RNAi Therapeutics 2012-2017E
Figure China 2012-2017E Antisense and RNAi Therapeutics Sales Price (USD/Unit)
Figure China 2016 Antisense and RNAi Therapeutics Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Antisense and RNAi Therapeutics 2012-2017E
Figure Europe 2012-2017E Antisense and RNAi Therapeutics Sales Price (USD/Unit)
Figure Europe 2016 Antisense and RNAi Therapeutics Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Antisense and RNAi Therapeutics 2012-2017E
Figure Southeast Asia 2012-2017E Antisense and RNAi Therapeutics Sales Price (USD/Unit)
Figure Southeast Asia 2016 Antisense and RNAi Therapeutics Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Antisense and RNAi Therapeutics 2012-2017E
Figure Japan 2012-2017E Antisense and RNAi Therapeutics Sales Price (USD/Unit)
Figure Japan 2016 Antisense and RNAi Therapeutics Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Antisense and RNAi Therapeutics 2012-2017E
Figure India 2012-2017E Antisense and RNAi Therapeutics Sales Price (USD/Unit)
Figure India 2016 Antisense and RNAi Therapeutics Sales Market Share
Table Global 2012-2017E Antisense and RNAi Therapeutics Sales (K Units) by Type
Table Different Types Antisense and RNAi Therapeutics Product Interview Price
Table Global 2012-2017E Antisense and RNAi Therapeutics Sales (K Units) by Application
Table Different Application Antisense and RNAi Therapeutics Product Interview Price
Table Glaxo Smith Kline Information List
Table Product A Overview
Table Product B Overview
Table 2016 Glaxo Smith Kline Antisense and RNAi Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Glaxo Smith Kline Antisense and RNAi Therapeutics Business Region Distribution
Table Sanofi Aventis / Genzyme Information List
Table Product A Overview
Table Product B Overview
Table 2016 Sanofi Aventis / Genzyme Antisense and RNAi Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Sanofi Aventis / Genzyme Antisense and RNAi Therapeutics Business Region Distribution
Table Isis Pharmaceuticals/ Ionis Pharmaceuticals Information List
Table Product A Overview
Table Product B Overview
Table 2015 Isis Pharmaceuticals/ Ionis Pharmaceuticals Antisense and RNAi Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Isis Pharmaceuticals/ Ionis Pharmaceuticals Antisense and RNAi Therapeutics Business Region Distribution
Table Arbutus Biopharma Ltd. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Arbutus Biopharma Ltd. Antisense and RNAi Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Arbutus Biopharma Ltd. Antisense and RNAi Therapeutics Business Region Distribution
Table Silence Therapeutics Information List
Table Product A Overview
Table Product B Overview
Table 2016 Silence Therapeutics Antisense and RNAi Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Silence Therapeutics Antisense and RNAi Therapeutics Business Region Distribution
Table Bio-Path Holdings Inc. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Bio-Path Holdings Inc. Antisense and RNAi Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Bio-Path Holdings Inc. Antisense and RNAi Therapeutics Business Region Distribution
Table Calando Pharmaceuticals Information List
Table Product A Overview
Table Product B Overview
Table 2016 Calando Pharmaceuticals Antisense and RNAi Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Calando Pharmaceuticals Antisense and RNAi Therapeutics Business Region Distribution
Table ICo Therapeutics Information List
Table Product A Overview
Table Product B Overview
Table 2016 ICo Therapeutics Antisense and RNAi Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 ICo Therapeutics Antisense and RNAi Therapeutics Business Region Distribution
Table Quark Pharmaceuticals Information List
Table Product A Overview
Table Product B Overview
Table 2016 Quark Pharmaceuticals Antisense and RNAi Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Quark Pharmaceuticals Antisense and RNAi Therapeutics Business Region Distribution
Table Rexhan Pharmaceuticals Information List
Table Product A Overview
Table Product B Overview
Table 2016 Rexhan Pharmaceuticals Antisense and RNAi Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Rexhan Pharmaceuticals Antisense and RNAi Therapeutics Business Region Distribution
Table Biomarin/Prosensa Information List
Table Regulus Therapeutics Information List
Table Rxi Pharmaceuticals Information List
Table Silenseed Information List
Table Dicerna Pharmaceuticals Information List
Table Sirnaomics Inc Information List
Figure Global 2017-2022 Antisense and RNAi Therapeutics Market Size (K Units) and Growth Rate Forecast
Figure Global 2017-2022 Antisense and RNAi Therapeutics Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Antisense and RNAi Therapeutics Sales Price (USD/Unit) Forecast
Figure North America 2017-2022 Antisense and RNAi Therapeutics Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2017-2022 Antisense and RNAi Therapeutics Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2017-2022 Antisense and RNAi Therapeutics Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Antisense and RNAi Therapeutics Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2017-2022 Antisense and RNAi Therapeutics Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2017-2022 Antisense and RNAi Therapeutics Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Antisense and RNAi Therapeutics by Type 2017-2022
Table Global Consumption Volume (K Units) of Antisense and RNAi Therapeutics by Application 2017-2022
Table Traders or Distributors with Contact Information of Antisense and RNAi Therapeutics by Region